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Epidemiologic data of primary glomerular diseases in western
France. Between January 1, 1976, and December 31, 2002, his-
tologic diagnosis of primary glomerular diseases (PGD) was
made in 898 patients born and living at the time of diagnosis
in a region of France, comprising 412,735 inhabitants, of whom
391,265 were aged from 10 to 85 years. The prevalence of PGD
during a 75-year exposure to risk (10 to 85 years of age) was
evaluated to 6.9 in 1000 (8.2 in 1000 males and 5.1 in 1000
females) during the 27-year period. The most common PGD
was IgA nephropathy (IgAN) with a prevalence of 2.4 in 1000
(3.6 in 1000 males and 1.3 in 1000 females). The annual incidence
of PGD was evaluated separately for two consecutive 10-years
periods: period A (1976 to 1985), period B (1986 to 1995) and for
one 7-year period: period C (1996 to 2002). Within each of these
three periods, annual incidence of PGD was 89, 76, and 65 per
million inhabitants. During this 27-year period, the annual inci-
dences of membranoproliferative glomerulonephritis (GN) and
membranous nephropathy were declining and the incidence of
crescentic proliferative GN was strongly progressing, whereas
annual incidence of nephrosis remained stable. The incidence
of IgAN remained the same throughout the three periods: 28,
28, and 26 per million inhabitants. Whereas the incidence of
IgAN was three- to fourfold higher in the adult aged from 20 to
59 years than in the elderly during the periods A (38 vs. 11 per
million inhabitants) and B (37 vs. 12 per million inhabitants),
the incidence became similar whatever age groups during the
last period C (20 to 59 years, 25 per million inhabitants; 60 to
79 years, 27 per million inhabitants; and 80 years and over, 28
per million inhabitants. The stability of annual incidence ac-
cording to period and age, which is demonstrated for the first
time during the last period, provides a new evidence of a role
for genetic factors in the pathogenesis of IgAN.
The prevalence of primary glomerular diseases (PGD)
in the general population is difficult to evaluate be-
cause optimal conditions for performing epidemiologic
surveys are difficult to find. Since 1976, we are follow-
ing epidemiologic data of PGD in a region located in
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western France. Several previous reports at 10, 12, and
at 15 years demonstrated that the incidences of mem-
branoproliferative glomerulonephritis (GN) and post-
streptococcal acute GN were declining, whereas the inci-
dence of crescentic proliferative GN was increasing in the
study area [1]. This study reports our data at 27 years of
follow-up.
METHODS
This study was carried out from January 1, 1976, to
December 31, 2002, during which time renal biopsy was
performed in 1742 patients, of whom 898 (51.5%) had
PGD. All patients were born and living in the registry area
at the time of the diagnosis. The area was located in west-
ern France in the north of Brittany (Coˆtes d’Armor) and
comprised 412,735 inhabitants at the last census in 2000,
of whom 391,265 were aged from 10 to 80 years. This re-
gion has a homogeneous and stable population in terms of
migratory behavior (98.7% Caucasians). Only one hospi-
tal with a nephrology department served this population.
The Cotes d’Armor region fulfills the three criteria of a
standard metropolitan statistical area (SMSA): (1) a large
population nucleus with a city of 103,458 inhabitants; (2)
a total population over 100,000 in the area studied (the
studied region has 412,735 inhabitants); and (3) adjacent
communities well integrated with the population of the
major town. The method for delineating the area of med-
ical influence of our hospital was previously reported [1].
The diagnostic test for the epidemiologic survey was
renal biopsy. Unclassified diagnosis due to inadequate
sampling (less than five glomeruli for light microscopy or
absence of glomerulus for immunohistochemistry study)
concerned 2.3% of all renal biopsies. A diagnosis of PGD
was considered if there was, at the time of biopsy, (1)
no report of any known associated systemic disease; (2)
negative serology for hepatitis B virus (HBV), hepatitis
C virus (HCV after 1990), antinuclear factor; and (3) no
report of familial hematuria. Before 1992, serology for
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Fig. 1. Renal biopsy indications according to period. Abbreviations
are: ARF, acute renal failure; CRF, chronic renal failure; NS, nephrotic
syndrome; P, proteinuria; H, hematuria; A, period A (1976 to 1985);
B, period B (1986 to 1995); C, period C (1996 to 2002) (N = 663 renal
biopsies during the period).
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Fig. 2. Evolution of mean age at the time of renal biopsy years.
antineutrophil cytoplasmic antibody was not collected.
During the last period, crescentic proliferative GN with
positive serology was included if any systemic clinical
manifestation was present at the time of renal biopsy.
Renal biopsy specimens were processed and stained for
light microscopy and immunohistochemistry using poly-
clonal antisera against human IgG, IgM, IgA, C3, C1q,
kappa, and lambda light chains. Electron microscopy was
not systematically performed.
Clinical indications for renal biopsy during the
three consecutive periods under study are reported in
Figure 1. A progression of mean age at the time of renal
biopsy was observed (Fig. 2).
To evaluate the evolution of the incidence of PGD ac-
cording to period and age, we distinguished two consec-
utive 10-year periods (period A 1976 to 1985; period B
1986 to 1995) and one 7-year period (period C 1996 to
2002). Epidemiologic data were evaluated in a general
population of 4 million (periods A and B) and of 2.8 mil-
lion (period C) inhabitants.
Annual incidences of PGD and of each histologic form
in each age group (20 to 59 years; 60 to 79 years, and
80 years and over) of the general population at the time
of renal biopsy were studied. The annual incidence was
calculated as follows:
Annual incidence
= Total number of new patients for the period under studyPopulation in age group/duration of the period (years)
More than 81% of patients who started renal replace-
ment therapy with the diagnosis of PGD after January 1,
Table 1. Annual incidence of renal biopsy and of primary glomerular
disease (PGD) according to periods (number/per million)
Period A Period B Period C
1976 to 1985 1986 to 1995 1996 to 2002
Renal biopsy 170 175 141a
PGD 89 76 65b
aP < 0.02; bP < 0.01 with period A.
1981 had had a histologic diagnosis of renal disease. The
incidence of end-stage renal disease (ESRD) due to PGD
with histologic diagnosis was compared between two pe-
riods 1980 to 1987 and 1992 to 1999.
Results of incidence are given as number per million
inhabitants.
RESULTS
The mean annual incidence of PGD in the area was
77 per million inhabitants and the prevalence during a
75-year exposure to risk (10 to 85 years of age) was eval-
uated to 6.9 in 1000 (8.2 in 1000 males and 5.1 in 1000
females) during the 27-year period. The annual incidence
was significantly decreased in period C compared to pe-
riod A (Table 1). The incidence of PGD in the 20 to
59 years of age group significantly decreased during the
period C. In contrast, the incidence of PGD in the 60 to
79 years of age group increased in the last period
(Table 2). During the study period, the incidence of
ESRD due to PGD was evaluated to 20.3 (1980 to 1987)
and 25.6 (1992 to 1999) per million inhabitants. The dif-
ference was not significant.
Idiopathic IgA nephropathy (IgAN) was the most com-
mon PGD during all the period under study. The inci-
dence of IgAN remained the same throughout the three
periods: 28, 28, and 26 per million inhabitants. Peak of in-
cidence of diagnosis was between 20 and 59 years of age
during the two first periods. In period C, the incidence of
IgAN diagnosis in each age group was similar (Table 2).
A predominance of males was found in each age group
whatever the period and a significant decrease of the in-
cidence was observed during the period C in males, but
not in females (Fig. 3). The prevalence of IgAN was eval-
uated to 2.4 in 1000 (3.6 in 1000 males and 1.3 in 1000 fe-
males). Membranous nephropathy was the second most
frequent PGD in the general population living in the area.
Its annual incidence remained stable during periods A
and B whatever age group and decreased during period C
(Table 2). Compared with period B, the decrease of an-
nual incidence of membranous nephropathy diagnosis
was significant during period C in females, but not in
males (Fig. 3). The annual incidence of membranopro-
liferative GN and postreptococcal acute GN decreased
from the beginning of the study and this significant de-
crease was confirmed after a 27-year follow-up both in
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Table 2. Annual incidence (number/per million) of various histologic forms of primary glomerular disease (PGD) according to period and age
Period A (1976 to 1985) Period B (1986 to 1995) Period C (1996 to 2002)
Age group years 20 to 59 60 to 79 20 to 59 60 to 79 20 to 59 60 to 79 80 and over
IgA nephropathy 38 11 37 12 25 27 28
Membranous nephropathy 10 28 11 33 6 17 9
Nephrosis 9 8 8 8 8 11 28
Membranoproliferative glomerulonephritis 9 5 1 2 2 — —
Crescentic proliferative glomerulonephritis 1 5 2 15 4 27a 47
Otherb 4 27 10 22 8 27 10
Primary glomerular disease 71 84 69 92 53a 109a 122
aP < 0.02; bIncludes focal segmental glomerulosclerosis (without nephrotic syndrome), poststreptococcal acute glomerulonephritis, mesangial proliferative
glomerulonephritis, focal segmental proliferative glomerulonephritis (excluding Henoch Scho¨nlein disease).
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Fig. 3. Annual incidence of primary glomerular disease (PGD) accord-
ing to period and gender (incidence number/per million). Abbbrevia-
tions are: IsAN, IgA nephropathy (Bergers’ disease); MN, membranous
nephropathy; MC, minimal change; A, period A.
males as in females (Fig. 4). The annual incidence of cres-
centic proliferative GN significantly increased from the
beginning of the study in age group over 60 years of age.
The incidence in the 60 to 79 years of age group was
fivefold higher for period C than for period A (Table 2).
The most important increase of annual incidence was ob-
served in females (Fig. 4), particularly in those aged over
80 years of age (Table 2).
Incidence of ESRD due to IgA remained similar dur-
ing the whole study period. In contrast, ESRD due to
crescentic proliferative GN regularly increased. At the
end of the study period, ESRD due to crescentic prolif-
erative GN was threefold higher than at the beginning of
the study (Fig. 5).
DISCUSSION
This work reports on a 27-year prospective epidemi-
ologic study of PGD that started in January 1976 in the
area of Saint-Brieuc. Our results confirm those published
after 15 years of the study [1] and bring new data. We con-
firm that IgAN remains the most common PGD during
the whole study period in the general population of the
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Fig. 4. Annual incidence of primary glomerular disease (PGD) accord-
ing to period and gender (incidence number/per million). Abbreviations
are: MPGN, membranoproliferative glomerulonephritis type 1; acute
PGN, poststreptococcal acute glomerulonephritis; crescentic PGN,
idiopathic crescentic proliferative glomerulonephritis; A, period A.
∗∗P < 0.01; ∗P <0.05; +++P < 0.001 with period A.
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Fig. 5. Annual incidence of end-stage renal disease (ESRD) due to
biopsied primary glomerular disease (PGD) according to period (inci-
dence number/per million). Abbreviations are: Cresc. PGN, idiopathic
crescentric proliferative glomerulonephritis; IgAN, IgA nephropa-
thy; other, focal segmental glomerular sclerosis (with and without
nephrotic syndrome, membranous nephropathy, membranoprolifera-
tive glomerulonephritis. ++P < 0.01.
area. The new information furnished by this epidemio-
logic study is that the risk of occurrence of IgAN has
become similar in the population living in our region,
whatever the age group, during the last period. The mean
age of renal biopsy progressively increased during the
study period and the policy of renal biopsy was expanded
more and more in the elderly as the consequence of the
increase in average lifetime. So, the incidence of IgAN not
only remained similar throughout the period under study,
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but also became similar whatever age group during the
last period. The stability of the annual incidence of IgAN
diagnosis and of ESRD due to IgAN during this 27-year
prospective study strongly suggests that immunogenetic
factors could be more important that environmental fac-
tors in the onset of IgAN [2, 3].
In the area of the study, membranous nephropathy and
crescentic proliferative GN are the two most frequent
PGD in the elderly. The annual incidence of crescentic
proliferative GN diagnosis was fivefold higher at the end
than at the beginning of the study. Curiously, we observe a
dramatic increase of its annual incidence in females aged
over 80 years of age during the most recent study period.
The annual incidence of ESRD due to crescentic pro-
liferative GN was threefold higher during the last study
period than at the beginning of the study. In contrast, the
annual incidence of membranous nephropathy was de-
clining in the last period, particularly in females. In this
area, ESRD due to membranous nephropathy is rare. The
variability of annual incidence of these two PGD during
the study period suggests the possible role of some en-
vironmental factors such as infectious agents, drugs or
solvents, which could be in contact with the aged popu-
lation living in industrialized countries and which could
create an alteration in immune balance of the T-helper
subsets [4, 5].
We also confirm that the decline in membranoprolif-
erative GN and poststreptococcal acute GN was closely
associated in this area. Previously, we demonstrated that
the decline in acute rheumatic fever was also associated
to the decline in these two PGD [6]. Such a decline in
these diseases is commonly attributed to an improved
standard of living, better public health, and the early an-
tibiotic treatment of pharyngeal infections. However, the
slight increase of the annual incidence of poststreptococ-
cal acute GN during the last period suggests that the
risk of reappearance of non-suppurative complications
of streptococcal infection can still occur [5].
In conclusion, our study gives epidemiologic informa-
tion on the evolution of PGD incidence in every age group
of a general population during a long observation period
of 27 years. It demonstrates that IgAN remains the major
chronic PGD. The stability of annual incidence according
to period and age, which is demonstrated for the first time
during the most recent period, provides a new evidence
of a role for genetic factors in the pathogenesis of IgAN.
In contrast, other PGD have a variable annual incidence
during the 27-year period, which is in favor of a role for
environmental factors in their pathogenesis. Today, cres-
centic proliferative GN and membranous nephropathy
have become the two most frequent PGD in the elderly.
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